Trials / Unknown
UnknownNCT02278016
Biological Markers for the Diagnosis of Central Nervous System Infective Diseases
Diagnosis Value of Procalcitonin, Interleukin-6, AgiotensininⅡin the Cerebrospinal Fluid of Patients With Central Nervous System Infective Diseases
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- Xijing Hospital · Academic / Other
- Sex
- All
- Age
- 13 Years
- Healthy volunteers
- Accepted
Summary
Bacterial meningitis is a potentially life-threatening disease that is associated with substantial neurological morbidity and mortality. Accurate diagnosis is essential to improve outcome and prevent antibiotic overuse. Here we try to explore new biological markers for the diagnosis of the central nervous system infection disease.
Detailed description
To investigate the diagnosis value of procalcitonin,interleukin-6, agiotensininⅡin the cerebrospinal fluid in the central nervous system infection disease.
Conditions
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2016-07-01
- Completion
- 2017-07-01
- First posted
- 2014-10-29
- Last updated
- 2016-01-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02278016. Inclusion in this directory is not an endorsement.